Federal Register / Vol. 82, No. 181 / Wednesday, September 20, 2017 / Notices 43985 

well as focus groups and interviews. For 

each population, we will collect data 

from (1) families (i.e., parents/caregivers 

of children and adolescents, as well as 

adolescents themselves) with special 

health care needs and ASD; and (2) the 

medical, social service and other 

providers who serve them. In addition, 

we will collect data from emergencyresponse agency representatives and 

experts in health information and 

communications technology to ask 

cross-cutting questions regarding the 

use of technology to communicate 

during disasters, and the perspectives 

and needs of individuals and agencies 

charged with leading disaster response 

efforts. 

The data resulting from this study 

will be used to develop specific tools, 

protocols, and message templates that 

can be used for communicating during 

emergencies and disasters with families 

with CYSHCN and ASD. 

CDC plans to begin the information 

collection one month after OMB 

approval and continue for twenty two 

months. Information in identifiable form 

will not be linked to interview 

responses. No CDC staff will participate 

in the collection of data or otherwise 

have contact with the participants. 

Drexel will store all the data, and CDC 

will only receive coded and aggregated 

data so it will not be possible to link 

responses with individual subjects. Data 

will be treated in a secure manner and 

will not be disclosed, unless otherwise 

compelled by law. 

The total estimated annualized time 

burden to respondents is 419 hours. 

This information collection request is 

a new request and approval is requested 

for 24 months. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Families/Caregivers (CYSHCN) ........................ CYSHCN Family/Caregiver Survey .................. 150 1 15/60 38 

Families/Caregivers (ASD) ................................ ASD Family/Caregiver Survey .......................... 200 1 15/60 50 

Providers (CYSHCN) ......................................... CYSHCN Provider Survey ................................ 250 1 15/60 63

Providers (ASD) ................................................. ASD Provider Survey ........................................ 150 1 15/60 38 

Families/Caregivers (CYSHCN) ........................ CYSHCN Family/Caregiver Interviews ............. 50 1 1 50 

Families/Caregivers (ASD) ................................ ASD Family/Caregiver Interviews ..................... 30 1 1 30 

Families/Caregivers (CYSHCN and ASD) ........ CYSHCN & ASD Family/Caregiver Evaluation 

Focus Group.

30 1 1.5 45 

Providers (CYSHCN) ......................................... CYSHCN Provider Focus Group ...................... 20 1 1.5 30 

Providers (ASD) ................................................. ASD Provider Focus Group .............................. 10 1 1.5 15 

Emergency Response Organizations ................ Emergency Response Focus Group ................ 10 1 1.5 15 

Health IT Professionals ..................................... Health IT Focus Group ..................................... 10 1 1.5 15 

Providers ............................................................ Provider Evaluation Focus Group ..................... 20 1 1.5 30 

Total ............................................................ ........................................................................... ........................ ........................ ........................ 419 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2017–19959 Filed 9–19–17; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–17–0666] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) has submitted the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. CDC previously 

published a ‘‘Proposed Data Collection 

Submitted for Public Comment and 

Recommendations’’ notice on May 30, 

2017 to obtain comments from the 

public and affected agencies. CDC 

received one comment related to the 

first notice. The purpose of this notice 

is to allow an additional 30 days for 

public comments. 

Written comments and suggestions 

from the public and affected agencies 

concerning the proposed collection of 

information are encouraged. The Office 

of Management and Budget is 

particularly interested in comments 

that: 

(a) Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

(b) Evaluate the accuracy of the 

agencies estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

(c) Enhance the quality, utility, and 

clarity of the information to be 

collected; 

(d) Minimize the burden of the 

collection of information on those who 

are to respond, including, through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., permitting electronic submission of 

responses; and 

(e) Assess information collection 

costs. 

To request additional information on 

the proposed project or to obtain a copy 

of the information collection plan and 

instruments, call (404) 639–7570 or 

send an email to omb@cdc.gov. Direct 

written comments and/or suggestions 

regarding the items contained in this 

notice to the Attention: CDC Desk 

Officer, Office of Management and 

Budget, 725 17th Street NW., 

Washington, DC 20503 or by fax to (202) 

395–5806. Provide written comments 

within 30 days of notice publication. 

Proposed Project 

National Healthcare Safety Network 

(NHSN) (OMB No. 0920–0666), exp. 

11/30/2019—Revision—National Center 

for Emerging and Zoonotic Infectious 

Diseases (NCEZID), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

The National Healthcare Safety 

Network (NHSN) is a system designed to 

accumulate, exchange, and integrate 

relevant information and resources 

among private and public stakeholders 

to support local and national efforts to 

protect patients and promote healthcare 

safety. Specifically, CDC uses the data to 


sradovich on DSKBBY8HB2PROD with NOTICES
43986 Federal Register / Vol. 82, No. 181 / Wednesday, September 20, 2017 / Notices 

determine the magnitude of various 

healthcare-associated adverse events 

and trends in the rates of these events 

among patients and healthcare workers 

with similar risks. CDC will use the data 

to detect changes in the epidemiology of 

adverse events resulting from new and 

current medical therapies and changing 

risks. 

The NHSN currently consists of five 

components: Patient Safety, Healthcare 

Personnel Safety, Biovigilance, LongTerm Care Facility (LTCF), and Dialysis. 

CDC will release the NHSN ‘‘Outpatient 

Procedure Component’’ in 2018. CDC’s 

request for additional user feedback and 

support from outside partners delayed 

development of this component. 

After receiving user feedback and 

internal review feedback, CDC made 

changes to six facility surveys. For the 

annual facility surveys, CDC amended, 

removed, or added questions and 

response options to fit the survey’s 

evolving uses. In addition, CDC and its 

partners use the surveys to help 

intelligently interpret the other data 

elements reported into NHSN. 

Currently, the surveys are used to 

appropriately risk adjust the numerator 

and denominator data entered into 

NHSN while also guiding decisions on 

future division priorities for prevention. 

Further, two new forms were added to 

expand NHSN surveillance to enhance 

data collection by Ambulatory Surgical 

Centers to identify areas where 

prevention of SSIs may be improved. 

CDC modified an additional 14 forms 

within the Hemovigilance module to 

streamline data collection/entry for 

adverse reaction events. 

Overall, CDC has made minor 

revisions to a total of 44 forms within 

the package to clarify and/or update 

surveillance definitions, increase or 

decrease the number of reporting 

facilities, and adding 2 new forms. The 

previously approved NHSN information 

collection package included 70 

individual collection forms; the current 

revision request includes 72 forms. The 

reporting burden will increase by 

811,985 hours, for a total of 5,922,953 

hours. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form No. & name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(hours) 

Registered Nurse (Infection 

Preventionist).

57.100 NHSN Registration Form ............................................ 2,000 1 5/60 

Registered Nurse (Infection 

Preventionist).

57.101 Facility Contact Information ........................................ 2,000 1 10/60 

Registered Nurse (Infection 

Preventionist).

57.103 Patient Safety Component—Annual Hospital Survey 5,000 1 55/60 

Registered Nurse (Infection 

Preventionist).

57.105 Group Contact Information ......................................... 1,000 1 5/60 

Registered Nurse (Infection 

Preventionist).

57.106 Patient Safety Monthly Reporting Plan ...................... 6,000 12 15/60 

Registered Nurse (Infection 

Preventionist).

57.108 Primary Bloodstream Infection (BSI) .......................... 6,000 44 30/60 

Registered Nurse (Infection 

Preventionist).

57.111 Pneumonia (PNEU) .................................................... 6,000 72 30/60 

Registered Nurse (Infection 

Preventionist).

57.112 Ventilator-Associated Event ....................................... 6,000 144 25/60 

Registered Nurse (Infection 

Preventionist).

57.113 Pediatric Ventilator-Associated Event (PedVAE) ....... 2,000 120 25/60 

Registered Nurse (Infection 

Preventionist).

57.114 Urinary Tract Infection (UTI) ....................................... 6,000 40 20/60 

Registered Nurse (Infection 

Preventionist).

57.115 Custom Event ............................................................. 2,000 91 35/60 

Staff RN ............................... 57.116 Denominators for Neonatal Intensive Care Unit 

(NICU).

6,000 12 4 

Staff RN ............................... 57.117 Denominators for Specialty Care Area (SCA)/Oncology (ONC).6,000 9 5 

Staff RN ............................... 57.118 Denominators for Intensive Care Unit (ICU)/Other locations (not NICU or SCA).6,000 60 5 

Registered Nurse (Infection 

Preventionist).

57.120 Surgical Site Infection (SSI) ....................................... 6,000 36 35/60 

Staff RN ............................... 57.121 Denominator for Procedure ........................................ 6,000 540 10/60 

Laboratory Technician ......... 57.123 Antimicrobial Use and Resistance (AUR)—Microbiology Data Electronic Upload Specification Tables.6,000 12 5/60 

Pharmacist ........................... 57.124 Antimicrobial Use and Resistance (AUR)—Pharmacy 

Data Electronic Upload Specification Tables.

6,000 12 5/60 

Registered Nurse (Infection 

Preventionist).

57.125 Central Line Insertion Practices Adherence Monitoring.100 100 25/60 

Registered Nurse (Infection 

Preventionist).

57.126 MDRO or CDI Infection Form ..................................... 6,000 72 30/60 

Registered Nurse (Infection 

Preventionist).

57.127 MDRO and CDI Prevention Process and Outcome 

Measures Monthly Monitoring.

6,000 24 15/60 

Registered Nurse (Infection 

Preventionist).

57.128 Laboratory-identified MDRO or CDI Event ................. 6,000 240 20/60 

Registered Nurse (Infection 

Preventionist).

57.129 Adult Sepsis ................................................................ 50 250 25/60 

Registered Nurse (Infection 

Preventionist).

57.137 Long-Term Care Facility Component—Annual Facility Survey.2,600 1 2 


sradovich on DSKBBY8HB2PROD with NOTICES
Federal Register / Vol. 82, No. 181 / Wednesday, September 20, 2017 / Notices 43987 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondent Form No. & name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(hours) 

Registered Nurse (Infection 

Preventionist).

57.138 Laboratory-identified MDRO or CDI Event for LTCF 2,600 12 15/60 

Registered Nurse (Infection 

Preventionist).

57.139 MDRO and CDI Prevention Process Measures 

Monthly Monitoring for LTCF.

2,600 12 10/60 

Registered Nurse (Infection 

Preventionist).

57.140 Urinary Tract Infection (UTI) for LTCF ....................... 2,600 14 30/60 

Registered Nurse (Infection 

Preventionist).

57.141 Monthly Reporting Plan for LTCF .............................. 2,600 12 5/60 

Registered Nurse (Infection 

Preventionist).

57.142 Denominators for LTCF Locations ............................. 2,600 12 4 

Registered Nurse (Infection 

Preventionist).

57.143 Prevention Process Measures Monthly Monitoring 

for LTCF.

2,600 12 5/60 

Registered Nurse (Infection 

Preventionist).

57.150 LTAC Annual Survey .................................................. 400 1 55/60 

Registered Nurse (Infection 

Preventionist).

57.151 Rehab Annual Survey ................................................ 1,000 1 55/60 

Occupational Health RN/ 

Specialist.

57.200 Healthcare Personnel Safety Component Annual Facility Survey.50 1 8 

Occupational Health RN/ 

Specialist.

57.203 Healthcare Personnel Safety Monthly Reporting Plan 17,000 1 5/60 

Occupational Health RN/ 

Specialist.

57.204 Healthcare Worker Demographic Data ...................... 50 200 20/60 

Occupational Health RN/ 

Specialist.

57.205 Exposure to Blood/Body Fluids .................................. 50 50 1 

Occupational Health RN/ 

Specialist.

57.206 Healthcare Worker Prophylaxis/Treatment ................ 50 30 15/60 

Laboratory Technician ......... 57.207 Follow-Up Laboratory Testing .................................... 50 50 15/60 

Occupational Health RN/ 

Specialist.

57.210 Healthcare Worker Prophylaxis/Treatment-Influenza 50 50 10/60 

Medical/Clinical Laboratory 

Technologist.

57.300 Hemovigilance Module Annual Survey ...................... 500 1 2 

Medical/Clinical Laboratory 

Technologist.

57.301 Hemovigilance Module Monthly Reporting Plan ........ 500 12 1/60 

Medical/Clinical Laboratory 

Technologist.

57.303 Hemovigilance Module Monthly Reporting Denominators.500 12 1.17 

Medical/Clinical Laboratory 

Technologist.

57.305 Hemovigilance Incident .............................................. 500 10 10/60 

Medical/Clinical Laboratory 

Technologist.

57.306 Hemovigilance Module Annual Survey—Non-acute 

care facility.

200 1 35/60 

Medical/Clinical Laboratory 

Technologist.

57.307 Hemovigilance Adverse Reaction—Acute Hemolytic 

Transfusion Reaction.

500 4 20/60 

Medical/Clinical Laboratory 

Technologist.

57.308 Hemovigilance Adverse Reaction—Allergic Transfusion Reaction.500 4 20/60 

Medical/Clinical Laboratory 

Technologist.

57.309 Hemovigilance Adverse Reaction—Delayed Hemolytic Transfusion Reaction.500 1 20/60 

Medical/Clinical Laboratory 

Technologist.

57.310 Hemovigilance Adverse Reaction—Delayed Serologic Transfusion Reaction.500 2 20/60 

Medical/Clinical Laboratory 

Technologist.

57.311 Hemovigilance Adverse Reaction—Febrile Non-hemolytic Transfusion Reaction.500 4 20/60 

Medical/Clinical Laboratory 

Technologist.

57.312 Hemovigilance Adverse Reaction—Hypotensive 

Transfusion Reaction.

500 1 20/60 

Medical/Clinical Laboratory 

Technologist.

57.313 Hemovigilance Adverse Reaction—Infection ............. 500 1 20/60 

Medical/Clinical Laboratory 

Technologist.

57.314 Hemovigilance Adverse Reaction—Post Transfusion 

Purpura.

500 1 20/60 

Medical/Clinical Laboratory 

Technologist.

57.315 Hemovigilance Adverse Reaction—Transfusion Associated Dyspnea.500 1 20/60 

Medical/Clinical Laboratory 

Technologist.

57.316 Hemovigilance Adverse Reaction—Transfusion Associated Graft vs. Host Disease.500 1 20/60 

Medical/Clinical Laboratory 

Technologist.

57.317 Hemovigilance Adverse Reaction—Transfusion Related Acute Lung Injury.500 1 20/60 

Medical/Clinical Laboratory 

Technologist.

57.318 Hemovigilance Adverse Reaction—Transfusion Associated Circulatory Overload.500 2 20/60 

Medical/Clinical Laboratory 

Technologist.

57.319 Hemovigilance Adverse Reaction—Unknown Transfusion Reaction.500 1 20/60 

Medical/Clinical Laboratory 

Technologist.

57.320 Hemovigilance Adverse Reaction—Other Transfusion Reaction.500 1 20/60 

Medical/Clinical Laboratory 

Technologist.

57.400 Patient Safety Component—Annual Facility Survey .. 5,000 1 5/60 


sradovich on DSKBBY8HB2PROD with NOTICES
43988 Federal Register / Vol. 82, No. 181 / Wednesday, September 20, 2017 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Type of respondent Form No. & name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(hours) 

Staff RN ............................... 57.401 Outpatient Procedure Component—Monthly Reporting Plan.5,000 12 15/60 

Staff RN ............................... 57.402 Outpatient Procedure Component—Same Day Outcome Measures & Prophylactic Intravenous (IV) Antibiotic 

Timing Event.

5,000 25 40/60 

Staff RN ............................... 57.403 Outpatient Procedure Component—Monthly Denominators for Same Day Outcome Measures & Prophylactic Intravenous (IV) Antibiotic Timing Event.5,000 12 40/60 

Staff RN ............................... 57.404 Outpatient Procedure Component—Annual Facility 

Survey.

5,000 540 10/60 

Registered Nurse (Infection 

Preventionist).

57.405 Outpatient Procedure Component—Surgical Site 

(SSI) Event.

5,000 36 35/60 

Staff RN ............................... 57.500 Outpatient Dialysis Center Practices Survey ............. 7,000 1 2.0 

Registered Nurse (Infection 

Preventionist).

57.501 Dialysis Monthly Reporting Plan ................................ 7,000 12 5/60 

Staff RN ............................... 57.502 Dialysis Event ............................................................. 7,000 60 25/60 

Staff RN ............................... 57.503 Denominator for Outpatient Dialysis .......................... 7,000 12 10/60 

Staff RN ............................... 57.504 Prevention Process Measures Monthly Monitoring 

for Dialysis.

2,000 12 1.25 

Staff RN ............................... 57.505 Dialysis Patient Influenza Vaccination ....................... 325 75 10/60 

Staff RN ............................... 57.506 Dialysis Patient Influenza Vaccination Denominator .. 325 5 10/60 

Staff RN ............................... 57.507 Home Dialysis Center Practices Survey .................... 350 1 30/60 

Leroy A. Richardson, 

Chief, Information Collection Review Office, 

Office of Scientific Integrity, Office of the 

Associate Director for Science, Office of the 

Director, Centers for Disease Control and 

Prevention. 

[FR Doc. 2017–20009 Filed 9–19–17; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60Day–17–0822; Docket No. CDC 2017– 

0067] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice with comment period. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), as part of 

its continuing efforts to reduce public 

burden and maximize the utility of 

government information, invites the 

general public and other Federal 

agencies to take this opportunity to 

comment on proposed and/or 

continuing information collections, as 

required by the Paperwork Reduction 

Act of 1995. This notice invites 

comment on The National Intimate 

Partner and Sexual Violence Survey 

(NISVS) to collect information about 

individual’s experiences of sexual 

violence, stalking and intimate partner 

violence and information about the 

health consequences of these forms of 

violence. CDC produces national and 

state level prevalence estimates of these 

types of violence. 

DATES: Written comments must be 

received on or before November 20, 

2017. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2017– 

0067 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulations.gov. Follow the instructions 

for submitting comments. 

• Mail: Leroy A. Richardson, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE., MS– 

D74, Atlanta, Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. All relevant comments 

received will be posted without change 

to Regulations.gov, including any 

personal information provided. For 

access to the docket to read background 

documents or comments received, go to 

Regulations.gov. 

Please note: All public comment should be 

submitted through the Federal eRulemaking 

portal Regulations.gov) or by U.S. mail to the 

address listed above. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the information collection plan and 

instruments, contact Leroy Richardson, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE., MS– 

D74, Atlanta, Georgia 30329; phone: 

404–639–7570; Email: omb@cdc.gov. 

SUPPLEMENTARY INFORMATION: 

Under the Paperwork Reduction Act 

of 1995 (PRA) (44 U.S.C. 3501–3520), 

Federal agencies must obtain approval 

from the Office of Management and 

Budget (OMB) for each collection of 

information they conduct or sponsor. In 

addition, the PRA also requires Federal 

agencies to provide a 60-day notice in 

the Federal Register concerning each 

proposed collection of information, 

including each new proposed 

collection, each proposed extension of 

existing collection of information, and 

each reinstatement of previously 

approved information collection before 

submitting the collection to OMB for 

approval. To comply with this 

requirement, we are publishing this 

notice of a proposed data collection as 

described below. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 


sradovich on DSKBBY8HB2PROD with NOTICES